Posaconazole
Common brands: Noxafil, Zovirax, Acyclovir, Acyclovir Suspension, Avaclyr
Top reporter: Merck Sharp & Dohme Llc
Azole Antifungal [EPC]Corticosteroid [EPC]Nucleoside Metabolic Inhibitor [EPC]Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
15,720
Total Reports
9,313
Serious Reports
3,791
Death Reports
30
Reported Reactions
Death Report Ratio: High (24.12%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Posaconazole.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | OFF LABEL USE | 1,593 | |
| 2 | DRUG INEFFECTIVE | 1,457 | |
| 3 | FEBRILE NEUTROPENIA | 1,039 | |
| 4 | PRODUCT USE IN UNAPPROVED INDICATION | 977 | |
| 5 | DEATH | 958 | |
| 6 | DRUG INTERACTION | 952 | |
| 7 | PYREXIA | 870 | |
| 8 | NEUTROPENIA | 724 | |
| 9 | PNEUMONIA | 665 | |
| 10 | THROMBOCYTOPENIA | 515 | |
| 11 | DIARRHOEA | 507 | |
| 12 | NAUSEA | 492 | |
| 13 | SEPTIC SHOCK | 450 | |
| 14 | CONDITION AGGRAVATED | 432 | |
| 15 | ACUTE KIDNEY INJURY | 419 | |
| 16 | SEPSIS | 418 | |
| 17 | FATIGUE | 405 | |
| 18 | PANCYTOPENIA | 370 | |
| 19 | DYSPNOEA | 324 | |
| 20 | VOMITING | 324 | |
| 21 | ACUTE MYELOID LEUKAEMIA | 310 | |
| 22 | ANAEMIA | 297 | |
| 23 | INFECTION | 292 | |
| 24 | HYPOKALAEMIA | 289 | |
| 25 | PLATELET COUNT DECREASED | 288 | |
| 26 | ASTHENIA | 287 | |
| 27 | DISEASE PROGRESSION | 284 | |
| 28 | PRODUCT USE ISSUE | 273 | |
| 29 | RESPIRATORY FAILURE | 273 | |
| 30 | RENAL FAILURE | 268 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.